首页 | 本学科首页   官方微博 | 高级检索  
检索        

银杏叶提取物对2型糖尿病大鼠肝脏糖皮质激素受体表达的影响
引用本文:郑海红,苏志涛,肖艳,王环,王蓉蓉,牛三强,吴亮,万丽,陈丽玲,陈筱菲,陈国荣.银杏叶提取物对2型糖尿病大鼠肝脏糖皮质激素受体表达的影响[J].中国病理生理杂志,2009,25(5):934-938.
作者姓名:郑海红  苏志涛  肖艳  王环  王蓉蓉  牛三强  吴亮  万丽  陈丽玲  陈筱菲  陈国荣
作者单位:温州医学院附属第一医院 1病理科, 2检验科, 浙江 温州 325000
基金项目:浙江省科技计划攻关项目,温州医学院重大项目 
摘    要:目的: 观察银杏叶提取物(EGB)对2型糖尿病大鼠肝脏糖皮质激素受体(GR)表达的影响,并探讨其机制。方法:雄性SD大鼠30只随机均分成3组:正常对照组、糖尿病对照组、EGB干预组。后两组采用高脂饮食4周,按30 mg/kg 腹腔注射链脲佐菌素(STZ) 诱导2 型糖尿病大鼠模型, EGB干预组给予50 mg·kg-1·d-1EGB连续灌胃12周。治疗结束取血生化检测血糖、血脂水平,放免法检测血胰岛素水平,HE染色光镜下观察肝脏组织的形态学改变,以RT-PCR法检测肝组织GR mRNA的表达水平,免疫组化法检测肝组织GR蛋白表达水平。结果:EGB可降低糖尿病大鼠血糖、血脂、血胰岛素水平,减轻肝细胞脂肪变性、坏死、炎细胞浸润,使肝组织GR mRNA的表达与蛋白表达明显减低。结论:EGB具有抑制2型糖尿病大鼠肝脏GR基因mRNA表达与蛋白表达的作用,这可能是其降低2型糖尿病大鼠血糖、血脂水平,改善肝内脂肪沉积的重要机制之一。

关 键 词:糖尿病  银杏叶提取物    受体  糖皮质激素  
收稿时间:2008-6-4
修稿时间:2009-2-12

Effects of extract of gingko biloba on expression of glucocorticoid receptor in hepatic tissues from type 2 diabetic rats
ZHENG Hai-hong,SU Zhi-tao,XIAO Yan,WANG Huan,WANG Rong-rong,NIU San-qiang,WU Liang,WAN Li,CHEN Li-ling,CHEN Xiao-fei,CHEN Guo-rong.Effects of extract of gingko biloba on expression of glucocorticoid receptor in hepatic tissues from type 2 diabetic rats[J].Chinese Journal of Pathophysiology,2009,25(5):934-938.
Authors:ZHENG Hai-hong  SU Zhi-tao  XIAO Yan  WANG Huan  WANG Rong-rong  NIU San-qiang  WU Liang  WAN Li  CHEN Li-ling  CHEN Xiao-fei  CHEN Guo-rong
Institution:1Department of Pathology, 2Department of Clinical Laboratory Medicine, The First Affiliated Hospital, Wenzhou Medical College, Wenzhou 325000, China. E-mail: chengr1978@yahoo.com.cn
Abstract:AIM: To study the effect and mechanism of extract of ginkgo biloba (EGB) on liver glucocorticoid receptor (GR) expression in type 2 diabetic rats. METHODS: Thirty male Sprague-Dawley rats were divided randomly into three groups: normal control group (n=10), type 2 diabetic group (n=10) and ginkgo biloba treated group (n=10). After fed with high-fat feeding for 4 weeks, the later two groups were injected with streptozotocin at a dose of 30 mg/kg intraperitoneally to induce type 2 diabetic rat model. The EGB treated group was gavaged with EGB at the dose of 50 mg·kg-1·d-1 for 12 weeks. At the end of experiment, the rats were sacrificed, the blood glucose, serum lipid and blood insulin were measured. The morphology of liver tissue was observed under light microscopy with HE staining. GR mRNA expression in liver was measured by RT-PCR. The level of GR protein expression in liver tissue was detected by immunohistochemistry. RESULTS: EGB reduced the levels of blood glucose, blood lipids, blood insulin in diabetic rats. EGB also relieved fatty degeneration and necrosis of the hepatic cells, ameliorated infiltration of inflammatory cells in the liver; and decreased GR expression at both mRNA and protein levels in diabetic liver. CONCLUSION: EGB may inhibit GR expression in liver of type 2 diabetic rats, which results in decreasing the level of blood glucose, blood lipid, blood insulin and relieving the liver damage in type diabetic rats.
Keywords:Diabetes mellitus  Extract of ginkgo biloba  Liver  Receptors  glucocorticoid  Gene expression
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《中国病理生理杂志》浏览原始摘要信息
点击此处可从《中国病理生理杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号